rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
1996-5-28
|
pubmed:abstractText |
This retrospective study evaluates the results of a regimen of high-dose intrathecal methotrexate and the prognostic factors for the response in patients with meningeal from breast carcinoma.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0008-543X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
77
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1315-23
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:8608509-Adult,
pubmed-meshheading:8608509-Aged,
pubmed-meshheading:8608509-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8608509-Breast Neoplasms,
pubmed-meshheading:8608509-Carcinoma,
pubmed-meshheading:8608509-Dose-Response Relationship, Drug,
pubmed-meshheading:8608509-Female,
pubmed-meshheading:8608509-Humans,
pubmed-meshheading:8608509-Hydrocortisone,
pubmed-meshheading:8608509-Injections, Spinal,
pubmed-meshheading:8608509-Leucovorin,
pubmed-meshheading:8608509-Meningeal Neoplasms,
pubmed-meshheading:8608509-Methotrexate,
pubmed-meshheading:8608509-Middle Aged,
pubmed-meshheading:8608509-Prognosis,
pubmed-meshheading:8608509-Retrospective Studies
|
pubmed:year |
1996
|
pubmed:articleTitle |
Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen.
|
pubmed:affiliation |
Service de Médecine Oncologique, Institut Curie, Paris, France.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study
|